Works matching IS 21641153 AND DT 2016 AND VI 6

Results: 41

Navigating the New Requirements for USP 800 Drugs.

Published in:: Journal of Hematology Oncology Pharmacy, 2016, v. 6, n. 4, p. 161
Publication type:: Article

Lowering the High Cost of USP 800 Compliance.

Published in:: Journal of Hematology Oncology Pharmacy, 2016, v. 6, n. 4, p. 160
Publication type:: Article

Challenges in ALK-Positive NSCLC Management.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, n. 4, p. 158

By:

Barbor, Meg

Publication type:

Article

Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy.

Published in:: 2016
Publication type:: Abstract

Making an Informed Treatment Choice for Aggressive Non-Hodgkin Lymphoma: The R-CHOP Regimen versus EPOCH-R.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, n. 4, p. 145

By:

Curry, Marjorie Adams;
Liewer, Susanne

Publication type:

Article

Efficacy and Cost Analysis of a Plerixafor Protocol for Peripheral Blood Stem-Cell Mobilization in Patients with Multiple Myeloma or Non-Hodgkin Lymphoma.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, n. 4, p. 139

By:

Wehr, Victoria H.;
Comeau, Jill M.

Publication type:

Article

Overview of the Current Development Landscape in Chronic Lymphocytic Leukemia, Part 3.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, n. 4, p. 124

By:

Combest, Austin J.;
Danford, Ryan C.;
Andrews, Elizabeth R.;
Simmons, Ashley;
McAtee, Paulina;
Reitsma, Dirk J.

Publication type:

Article

New and Emerging Developments in the Management of Chronic Lymphocytic Leukemia: Role of the Pharmacist.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, n. 4, p. 122

By:

Medina, Patrick J.

Publication type:

Article

The Effect of Written Pharmacist-Provided Patient Education for 3 Frequently Prescribed Oral Anticancer Agents on the Incidence of Patient-Initiated Triage Calls.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, n. 3, p. 72

By:

De Padova, Nicolas;
Grabowski, Robert;
Ineck, Joseph;
Mancini, Robert

Publication type:

Article

Overview of the Current Treatment Paradigm in Chronic Lymphocytic Leukemia, Part 2.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, n. 3, p. 89

By:

Combest, Austin J.;
Danford, Ryan C.;
Andrews, Elizabeth R.;
Simmons, Ashley;
Mcatee, Paulina;
Reitsma, Dirk J.

Publication type:

Article

The Importance of Monitoring Cardiotoxicity in Patients with Breast Cancer.

Published in:

2016

By:

Cuellar, Sandra

Publication type:

Opinion

HER2 Receptor Antagonist–Associated Cardiotoxicity.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, n. 3, p. 85

By:

Palumbo, Alison;
Bubalo, Joseph

Publication type:

Article

Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, n. 3, p. 108

By:

Ignoffo, Robert J.

Publication type:

Article

Adjusted Dosing and Schedule of Pemetrexed in Impaired Renal Function.

Published in:

2016

By:

Ohana, Zahava;
Brahim, Amanda;
Ibrahim, Mohammed

Publication type:

Case Study

Overview of the Recent Developments in Chronic Lymphocytic Leukemia, Part 1.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, n. 2, p. 54

By:

Combest, Austin J.;
Danford, Ryan C.;
Andrews, Elizabeth R.;
Simmons, Ashley;
McAtee, Paulina;
Reitsma, Dirk J.

Publication type:

Article

Determination of Extended Sterility for Single-Use Vials Using the PhaSeal Closed-System Transfer Device.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, n. 2, p. 46

By:

Ho, Kristin V.;
Edwards, Michael S.;
Solimando Jr., Dominic A.;
Johnson, Anthony D.

Publication type:

Article

Cyanocobalamin/Salcaprozate Sodium: A Novel Way to Treat Vitamin B<sub>12</sub> Deficiency and Anemia.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, n. 2, p. 42

By:

Smith, Lillian;
Mosley, Juan;
Ford, Megan;
Courtney, Jonathan

Publication type:

Article

Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, n. 2, p. 57

By:

Ignoffo, Robert J.

Publication type:

Article

A Pipeline Preview of 2016 FDA Approvals in Hematology/Oncology.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, p. 105

By:

Beechinor, Ryan;
Valgus, John M.

Publication type:

Article

Zarxio (Filgrastim-sndz): First Biosimilar Approved in the United States.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, p. 100

By:

Raedler, Lisa A.

Publication type:

Article

Varubi (Rolapitant) Approved for the Prevention of Delayed-Onset Chemotherapy-Induced Nausea and Vomiting.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, p. 94

By:

Raedler, Lisa A.

Publication type:

Article

Revlimid (Lenalidomide) Now FDA Approved as First-Line Therapy for Patients with Multiple Myeloma.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, p. 90

By:

Raedler, Lisa A.

Publication type:

Article

Portrazza (Necitumumab), an IgG1 Monoclonal Antibody, FDA Approved for Advanced Squamous Non-Small-Cell Lung Cancer.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, p. 86

By:

Fala, Loretta

Publication type:

Article

Pomalyst (Pomalidomide) Received a New Indication for Patients with Relapsed and/or Refractory Multiple Myeloma.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, p. 82

By:

Raedler, Lisa A.

Publication type:

Article

Ninlaro (Ixazomib): First Oral Proteasome Inhibitor Approved for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, p. 66

By:

Raedler, Lisa A.

Publication type:

Article

Lonsurf (Trifluridine plus Tipiracil): A New Oral Treatment Approved for Patients with Metastatic Colorectal Cancer.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, p. 62

By:

Raedler, Lisa A.

Publication type:

Article

Keytruda (Pembrolizumab): First PD-1 Inhibitor Approved for the Treatment of Patients with Metastatic Non-Small-Cell Lung Cancer Expressing PD-L1.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, p. 58

By:

Raedler, Lisa A.

Publication type:

Article

Imlygic (Talimogene Laherparepvec): First Oncolytic Viral Therapy for the Treatment of Patients with Recurrent Melanoma.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, p. 54

By:

Raedler, Lisa A.

Publication type:

Article

Imbruvica (Ibrutinib): First Drug Approved for the Treatment of Patients with Waldenström's Macroglobulinemia.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, p. 50

By:

Raedler, Lisa A.

Publication type:

Article

Empliciti (Elotuzumab): First SLAMF7 Antibody Therapy Approved for the Treatment of Patients with Previously Treated Multiple Myeloma.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, p. 46

By:

Raedler, Lisa A.

Publication type:

Article

Darzalex (Daratumumab): First Anti-CD38 Monoclonal Antibody Approved for Patients with Relapsed Multiple Myeloma.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, p. 36

By:

Raedler, Lisa A.

Publication type:

Article

Bendeka (Bendamustine Hydrochloride): Rapid-Infusion Formulation Approved for Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphomas.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, p. 32

By:

Raedler, Lisa A.

Publication type:

Article

Alecensa (Alectinib), an Oral Tyrosine Kinase Inhibitor, Approved for Metastatic Non-Small-Cell Lung Cancer with ALK Mutation.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, p. 28

By:

Fala, Loretta

Publication type:

Article

FDA Approvals of Brand-Name Prescription Drugs in 2015.

Published in:: Journal of Hematology Oncology Pharmacy, 2016, v. 6, p. 14
Publication type:: Article

Translation of Benchtop Science Arrives in Force, Improves Patient Care.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, p. 12

By:

Adams, Val R.

Publication type:

Article

Welcome to the First Annual Oncology Pharmacy Guide to New FDA Approvals.

Published in:: Journal of Hematology Oncology Pharmacy, 2016, v. 6, p. 10
Publication type:: Article

Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, n. 1, p. 28

By:

Ignoffo, Robert J.

Publication type:

Article

Loss of Pregnancy in a Patient with Chronic Myeloid Leukemia During Treatment with Nilotinib.

Published in:

2016

By:

Arnall, Justin;
Muluneh, Benyam

Publication type:

Case Study

Management of Hypercalcemia of Malignancy.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, n. 1, p. 18

By:

Thomas, Sonia Amin;
Soo-hwan Chung

Publication type:

Article

Neutropenia Recovery Linked to Filgrastim Initiation Timing After Autologous Hematopoietic Stem-Cell Transplantation.

Published in:

Journal of Hematology Oncology Pharmacy, 2016, v. 6, n. 1, p. 12

By:

Janusek, Marissa;
Geswein, Laura;
DiGrazia, Lisa;
Schultz, Kathryn;
Crank, Christopher W.;
Fung, Henry C.

Publication type:

Article

Immunotherapy: 2015 Cancer Advance of the Year.

Published in:

2016

By:

Medina, Patrick J.

Publication type:

Editorial